Renales v. People
REITERATIONFacts
The Antecedents: In 1991-1992, Philippine Navy officers including petitioners LCDR Rosendo C. Roque (Naval Procurement Officer) and Ramon C. Renales (Head of Price Monitoring Office), along with superiors like Vice Admiral Mariano Dumancas, Jr., Commodore Francisco L. Tolin, and Commander Manuel R. Tuason, processed purchases of medicines totaling approximately P2,900,000 from five suppliers (Jerso Marketing, PMS Commercial, Gebruder Marketing, Dofra Pharmaceutical, Roddensers Pharmaceuticals) via emergency procurement without public bidding or canvass from three suppliers, as required by COA Circular No. 85-55-A. Requests originated from PN units like the Therapeutic Board of Dental Doctors and Medical Therapeutic Board, certifying medicines as 'badly needed' due to zero stocks in warehouses, amid rumors of a coup d'etat necessitating stockpiling; requisitions specified generic names but purchase orders used branded names with certifications of exclusive distributorship from suppliers and manufacturers. Roque ensured supporting documents including procurement directives, emergency purchase certificates, distribution lists, and exclusive distributorship certifications before issuing purchase orders. Renales, in comparative pricing analyses from his computerized database (updated via PIMS 1990-1992), noted 'not canvassed/prices noted' based on exclusive distributorship docs, authority for procurement, and end-user requisitions, claiming his role ministerial without power to alter requests or verify distributorship medically. COA audit (per Assignment Order No. 1507) by Director Mary S. Adelino examined vouchers, receipts, orders, requisitions, fund availability certificates, emergency certifications, distributorship proofs, manufacturer invoices/licenses, and price comparisons, finding no true emergency (medicines for stock, mostly over-the-counter like paracetamol, amoxicillin, multivitamins) and non-compliance with canvass even if emergency assumed. Procedural History: On August 5, 2011, Ombudsman filed 12 Informations for Sections 3(e) and 3(g), R.A. 3019 against 12 accused (8 arraigned not guilty: Roque, Renales, Dumancas, Aquino, Edulag, Tolin, Torres, Tuason; others at large). Torres's motion to quash for speedy trial violation denied by Sandiganbayan but granted by SC via Rule 65, dismissing his cases. Prosecution's sole witness Adelino testified on audit findings; defense presented Roque, Renales, and three others detailing procedures and reliance on medical certifications. Sandiganbayan (Jan. 12, 2017 Decision) convicted Roque (4 counts), Renales (5 counts), Dumancas, Tolin, Tuason of Sec. 3(e) (6 yrs 1 mo min to 10 yrs max + perpetual disqualification each count), acquitted all on Sec. 3(g) for unproven overpricing; acquitted Aquino. Roque/Renales MRs invoking Torres dismissal denied (May 9, 2017 Res.), citing their extensions in prelim investigation, case complexity (12 Infos, 12 accused, multiple transactions), and late raising of speedy trial. The Petition: Roque petitioned (July 3, 2017) assailing conviction/SB Res., claiming speedy trial violation per Torres, no criminal intent/bad faith as junior officer relying on superiors/doctors' urgent certifications/zero-stock info without medical background. Renales petitioned (May 25, 2017) arguing unproven Sec. 3(e) elements, ministerial duty only (price noting based on docs/database, no supplier knowledge/alteration power), and speedy trial breach. OSP countered Roque stuck to brands to skip canvass/favor suppliers; Renales failed generic price checks, used brands to prefer suppliers.
Issue(s)
Whether petitioners Roque and Renales are guilty beyond reasonable doubt of violation of Section 3(e) of R.A. 3019 for emergency medicine purchases without bidding/canvass. Whether the Sandiganbayan erred in finding manifest partiality, evident bad faith, undue injury, or unwarranted benefits despite reliance on certifications.
Ruling
Petitions GRANTED; Sandiganbayan Decision (Jan. 12, 2017) and Resolution (May 9, 2017) REVERSED and SET ASIDE; Roque and Renales ACQUITTED of Sec. 3(e), R.A. 3019 violations.
Ratio Decidendi
On Guilt under Section 3(e), R.A. 3019: The essential elements are: (1) public officer discharging official functions (undisputed for Roque/Renales); (2) acted with manifest partiality (clear notorious bias), evident bad faith (furtive design, corrupt motive, ill will, conscious wrong per Coloma, Jr. v. Sandiganbayan, Sistoza v. Desierto, People v. Sandiganbayan), or gross inexcusable negligence; (3) caused undue injury (actual quantified pecuniary loss per Llorente, Jr. v. Sandiganbayan, Rivera v. People, Abubakar v. People: substantial, proven with reasonable certainty, not speculative) or gave unwarranted benefit (unjustified advantage with dishonest intent per Martel v. People). Mere procurement violation (no emergency per COA Circular No. 85-55-A Sec. 4.1.b: no loss/danger to life/property, no undelayable project; no 3-supplier canvass; branded over generic use) insufficient alone, as clarified in Martel v. People citing Sabaldan, Jr. v. Ombudsman—requires independent proof of criminal intent beyond rules breach. Roque/Renales relied on multi-layer reviews: doctors' branded prescriptions, zero-stock/emergency certificates, exclusive distributorship affirmations from technical/medical boards—good-faith deference to experts negates bad faith/partiality absent connivance evidence (Villarosa v. People: illegal act ≠ bad faith sans furtive design). No personal supplier choice/ties shown; Renales's 'not canvassed' noting ministerial per docs/database (PIMS prices). SB's conspiracy finding unsupported by coordinated corrupt acts. Prosecution failed quantification: no canvass of same branded medicines' prices across suppliers for loss computation; SB conceded no overpricing (branded vs. generic differences due to marketing/packaging, acquitting on Sec. 3(g)). On Third Element (Undue Injury/Unwarranted Benefit): Undue injury needs 'actual damage' (Civil Code Art. 2199: pecuniary loss proven, fair compensation); unwarranted benefit demands corrupt grant (Gallego v. Sandiganbayan: lacking justification, with self-interest), not mere procedural favoritism (Martel: transgression alone insufficient sans unethical interest). No pecuniary gain to accused/suppliers proven; stock purpose amid coup rumors, over-the-counter meds justify reliance. Public bidding rationale (transparency, anti-corruption per Power Sector v. Pozzolanic) vital but violation doesn't auto-prove graft—prosecution burden un discharged. Speedy trial argument mooted by acquittal.
Main Doctrine
To convict under Section 3(e) of R.A. 3019 for procurement violations, the prosecution must prove beyond reasonable doubt not only the public officer's official act but also manifest partiality (clear, notorious bias favoring one side), evident bad faith (deliberate intent to do wrong via furtive design, self-interest, or ill will with corrupt motive), and either undue injury to the government (actual pecuniary loss, specified, quantified, and proven with reasonable certainty akin to civil compensatory damages, not based on speculation) or unwarranted benefits to private parties (unjustified advantage lacking official support, granted with dishonest purpose). Mere reliance on certifications from competent superiors or medical experts, such as zero-stock certificates or exclusive distributorship affirmations, does not equate to bad faith absent evidence of personal connivance or pecuniary gain. Violation of procurement rules like emergency purchase without canvass (COA Circular No. 85-55-A) or public bidding is insufficient alone, as graft requires independent criminal intent beyond administrative fault, per Martel v. People and Sabaldan, Jr. v. Ombudsman. Undue injury demands substantial, measurable damage, while unwarranted benefit necessitates proof of unethical preference tied to corruption, not procedural lapse. Thus, acquittal follows if elements are unproven, emphasizing transparency's role without criminalizing good-faith errors.